Bolt Biotherapeutics, Inc. Profile Avatar - Palmy Investing

Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor recep…

Biotechnology
US, Redwood City [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of BOLT's Analysis
CIK: 1641281 CUSIP: 097702104 ISIN: US0977021049 LEI: - UEI: -
Secondary Listings
BOLT has no secondary listings inside our databases.